Tovorafenib
| CAS No. | 1096708-71-2 | Cat. No. | BCP13797 |
| Name | Tovorafenib | ||
| Synonyms | TAK-580; TAK 580; TAK580; BIIB-024;BIIB 024;BIIB024;MLN 2480;MLN-2480;MLN2480; | ||
| Formula | C17H12Cl2F3N7O2S | M. Wt | 506.29 |
| Description | Tovorafenib is an orally available inhibitor of wild-type and certain mutant forms of A-Raf, B-Raf and C-Raf protein kinases, with potential antineoplastic activity. Upon administration, tovorafenib inhibits Raf-mediated signal transduction pathways, which may lead to an inhibition of tumor cell growth. Raf protein kinases play a key role in the RAF/MEK/ERK signaling pathway, which is often deregulated in human cancers and plays a key role in tumor cell proliferation and survival. | ||
| Pathways | MAPK Pathway | ||
| Targets | Raf | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.